Ординатура / Офтальмология / Английские материалы / Textbook of Vitreoretinal Diseases and Surgery_Natarajan, Hussain_2008
.pdf
Textbook of Vitreoretinal Diseases and Surgery
may be marred by ectopia lentis and poorly dilating pupils. Retinal breaks are commonly located along temporal periphery. (50% or more). Giant retinal tears are reported in 11% eyes.48 Uncomplicated detachments with clear media, centrally placed lens and peripheral break/s are managed with scleral buckling while complicated detachments need pars plana vitrectomy with internal tamponade, mostly silicone oil. Eyes undergoing pars plana vitrectomy invariably need lensectomy as the lens is usually subluxated in superotemporal quadrant. In general, anatomical success rate is in the range of 80 to 90%52 (combined scleral buckling and vitrectomy).
OUTCOME OF SURGERY IN PEDIATRIC RRD
Delay in diagnosis, higher incidence of PVR, need for multiple surgeries and associated congenital anamolies affect overall outcome in these eyes. The anatomical and functional results are summarized in Table 19-4.
TABLE 19-4: Surgery for pediatric RRD—results
Investigator |
n |
|
Surgery type (%) |
Mean Surg. |
|
|
Final success |
|||
|
|
|
||||||||
|
|
|
SB |
Vit |
per eye |
|
anat. |
|
functional |
|
|
|
|
|
|
|
|
|
|
||
Fivgas1 |
29 |
|
28 |
72 |
2.2 |
72 |
|
41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Butler7 |
15 |
|
80 |
— |
1.46 |
86.6 |
|
53.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weinberg6 |
39 |
|
41 |
13 (SB+PPV-46) |
1.6 |
79 |
|
50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Yokohama4 |
55 |
|
76 |
— |
— |
87 |
|
65 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Nagpal 8 |
111 |
|
61.26 |
38.73 |
1.29 |
78.37 |
|
98 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sadeh23 |
16 |
|
100 |
— |
— |
100 |
|
63 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Gonzales49 |
46 |
|
— |
74 |
— |
78 |
|
56 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Horle50 |
30 |
|
— |
100 |
— |
70 |
|
48.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Moisseiev51 |
28 |
|
— |
100 |
— |
32 |
|
18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Haring24 |
33 |
|
100 |
— |
— |
100 |
|
60.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Scleral buckling is the preferred procedure and vitrectomy was reserved for more complicated cases and in eyes with failed scleral buckle. Single surgery attachment rate is found to be around 60 to 80% while final attachment rate is around 80 to 90% in pediatric RRD. Gonzales, et al49 reported 78% anatomical attachment rate. The best anatomical results are noted in RDs with atrophic holes or dialysis (almost 100%) followed by tractional tears (74%) and giant retinal tears (67%). Younger age, worse initial vision, more extensive detachment, large and posterior tears and presence of PVR are associated with poor anatomical outcome.
Though not very encouraging, at least some degree of visual improvement is expected in about 60 to 70% of the cases. Haring et al24 reported 20/40 or better vision in 60.6% eyes following scleral buckling. Binocular vision could be achieved in 52.4% patients. Final visual acuity correlates well with presenting vision and is adversely affected by duration of the RD and presence of PVR. Visual rehabilitation is an integral part of the management following surgery in these eyes as amblyopia is a potential cause for visual impairment. There is life long risk of recurrent RD, glaucoma and cataract
238 indicating need for frequent prolonged follow-up.
Pediatric Retinal Detachment
Summary
The incidence of RRD is low in pediatric population. Ocular trauma/surgery and congenital structural abnormalities are the commonest etiological factors in this age group. There is higher incidence of bilateral involvement. Anatomical outcome is generally good following scleral buckling or vitrectomy.
Although visual improvement is modest, the value of surgery must be considered in context with the expected natural history of these eyes as, if left untreated, most will ultimately result in phthisis with irreversible vision loss. Delay in diagnosis, more frequent macular involvement, early and frequent development of PVR, preexisting congenital anomalies, development of amblyopia and lack of health care facilities are some of the chief reasons which limit the potential of visual recovery in these children.
In view of higher frequency of vision threatening abnormalities in the fellow eye, these patients need regular follow-up throughout their life. Once detected, prompt prophylactic treatment of asymptomatic lesions should be considered.
School vision screening tests, education of high risk patients and their parents regarding the threat of detachment and symptoms of the detachment can help in early diagnosis and treatment to improve overall final outcome. Finally improved surgical techniques may also help to reduce the incidence of pediatric RRD.
References
1.Fivgas GD, Capone A Jr. Pediatric rhegmatogenous retinal detachment. Retina 2001; 21:101-6.
2.Haimann MH, Burton TC, Brown CK. Epidemiology of retinal detachment Arch Ophthalmol 1982; 100:289-92.
3.Winslow RL, Tasman W. Juvenile rhegmatogenous retinal detachment Ophthalmology. 1978; 85:607-18.
4.Yokoyama T, Kato T, Minamoto A. et al Characteristics and surgical outcomes of pediatric retinal detachment. Eye 2004;18:889-92.
5.Ghazi NG, Green WR. Pathology and pathogenesis of retinal detachment. Eye 2002; 16:411-21.
6.Weinberg DV, Lyon AT, Greenwald MJ, Mets MB. Rhegmatogenous retinal detachments in children: risk factors and surgical outcomes. Ophthalmology 2003; 110:1708-13.
7.Butler TKH, Kiet AW, Orr GM. Anatomical and visual outcome of retinal detachment surgery in children. BJO 2001; 85:1437-9.
8.Nagpal M, Nagpal K, Rishi P, Nagpal PN. Juvenile rhegmatogenous retinal detachment. Indian J Ophthalmol 2004; 52:297-302.
9.Lee RWJ, Mayer EJ. The etiology of pediatric rhegmatogenous retinal detachment-15 years experience. Eye 2008; 22:636-40.
10.Schepens CL. Chapter 4. Pathogenesis of non traumatic rhegmatogenous retinal detachment. In-Retinal Detachment and Allied Diseases, Vol 1, WB Saunders 1983;37-67.
11.Ninn-Pedersen K, Bauer B. Cataract patients in a defined Swedish population, 1986 to 1990. V. Postoperative retinal detachments. Arch Ophthalmol 1996;114:382-6.
12.Katz J, Tielsch JM. Lifetime prevalence of ocular injuries from the Baltimore Eye Survey. Arch Ophthalmol 1993; 111:1564-8.
13.Sheard RM, Mireskandari K, Ezra E, Sullivan PM. Vitreoretinal surgery after childhood ocular trauma. Eye 2007;21:793-8.
14.Eagling EM. Ocular damage after blunt trauma to the eye. Its relationship to the nature of the injury. Br J Ophthalmol 1974 58:126-40.
15.Dugel PV, Ober RR. Chapter 139. Posterior segment manifestation in closed globe contusion injury. In Ryan SJ, Wilkinson (Eds), Retina, 4th edition, Vol 3, Mosby 2006;2365-77.
16.Ryan S, Yoon Y. Chapter 138-Posterior segment trauma-open globe contusion injury In Ryan SJ, Wilkinson (Eds). Retina, 4th edition, Vol 3, Mosby 2006;2353-64.
17.Javitt JC, Street DA, Tielsch JM, et al. National outcomes of cataract extraction. Retinal detachment and endophthalmitis after outpatient cataract surgery. Cataract Patient Outcomes Research Team. Ophthalmology 1994; 101:100-5.
18. Rabiah PK, Du h, Hahn EA. Frequency and predictors of retinal detachment after pediatric cataract surgery without |
239 |
primary intraocular lens implantation. J AAPOS 2005; 9:152-9. |
|
|
|
|
Textbook of Vitreoretinal Diseases and Surgery |
19. |
Hagler WS, North AW. Retinal dialyses and retinal detachment. Arch Ophthalmol 1968; 79:376-88. |
||
20. |
Weidenthal DT, Schepens CL. Peripheral fundus changes associated with ocular contusion. Am J Ophthalmol 1966; |
||
|
|
|
62:465-77. |
21. |
Smiddy WE, Loupe DN, Michels RG, et al. Refractive changes after scleral buckling surgery. Arch Ophthalmol |
||
|
|
|
1989;107:1469-71. |
22. |
MeierP,WiedemannP.Chapter145-Surgicalaspectsofvitreoretinaldiseasesinchildren.InRyanSJ,Wilkinson(Eds). |
||
|
|
|
Retina, 4th edition, Vol 3, Mosby 2006;2477-98. |
23. |
Sadeh AD, Dotan G, Bracha R, Lazar M, Loewenstein A. Characteristics and outcomes of paediatric rhegmatogenous |
||
|
|
|
retinal detachment treated by segmental scleral buckling plus an encircling element. Eye 2001; 15 (Pt 1):31-3. |
24. |
HaringG,WiechensB.Long-termresultsafterscleralbucklingsurgeryinuncomplicatedjuvenileretinaldetachment |
||
|
|
|
without proliferative vitreoretinopathy. Retina 1998; 18:501-5. |
25. |
Aiello AL, Tran VT, Rao NA. Postnatal development of the ciliary body and pars plana. A morphometric study in |
||
|
|
|
childhood. Arch Ophthalmol 1992; 110:802-5. |
26. |
Mark D J Greeve. Chapter 1.Vitreoretinal surgical anatomy. In Peyman G, Meffert S ( Eds). Vitreoretinal Surgical |
||
|
|
|
Techniques: Martin Dunitz Ltd 2001: pp 3-9. |
27. |
Hairston RJ, Maguire AM, Vitale S, Green WR. Morphometric analysis of pars plana development in humans. Retina |
||
|
|
|
1997; 17:135-8. |
28. |
Peyman GA, Canakis C, Livir-Rallatos C, Whalen P. Small-size pediatric vitrectomy wide-angle contact lens. Am J |
||
|
|
|
Ophthalmol 2003;135:236-7. |
29. |
T rese M, Capone A Jr. Chapter 23. Surgical approaches to infant and childhood retinal diseases-Invasive methods |
||
|
|
|
In Hartnett M (editor) Paediatric Retina, Lippincott A Williams and Wilkins 2005;359-64. |
30. |
Hesse L, Chofflet J, Kroll P. Tissue plasminogen activator as a biochemical adjuvant in vitrectomy for proliferative |
||
|
|
|
diabetic vitreoretinopathy. (Abstract) Ger J Ophthalmol 1995;4:323-7. |
31. |
Trese MT. Enzymatic-assisted vitrectomy. Eye 2002;16:365-8. |
||
32. |
Scott IU, Flynn HW Jr, Azen SP, et al. Silicone oil in the repair of pediatric complex retinal detachments: a prospective, |
||
|
|
|
observational, multicenter study. Ophthalmology 1999;106:1399-407; discussion 1407-8. |
33. |
ChengL,AzenSP,El-BradeyMH,etal.Durationofvitrectomyandpostoperativecataractinthevitrectomyformacular |
||
|
|
|
hole study. Am J Ophthalmol 2001;132:881-7. |
34. |
FerronePJ,HarrisonC,TreseMT. Lensclarityafterlens-sparingvitrectomyinapediatricpopulation.Ophthalmology |
||
|
|
|
1997;104:273-8. |
35. |
Jesbergd,SchepensCL.Retinaldetachmentassociatedwithcolobomaofthechoroid.ArchOphthalmol1961;65:163-73. |
||
36. |
Patnaik B, Kalsi R.Retinal detachment with coloboma of the choroid. Indian J Ophthalmol 1981;29:345-9. |
||
37. |
Gopal L, Badrinath SS, Sharma T. Surgical management of retinal detachments related to coloboma of the choroid. |
||
|
|
|
Ophthalmology 1998; 105:804-9. |
38. |
HannekenA,deJuanEJr,McCuenBW.Themanagementofretinaldetachmentsassociatedwithchoroidalcolobomas |
||
|
|
|
by vitreous surgery. Am J Ophthalmol 1991;111:271-5. |
39. |
Ferrone PJ, Trese MT, Lewis H. Vitreoretinal surgery for complications of congenital retinoschisis. Am J Ophthalmol |
||
|
|
|
1997; 123:742-7. |
40. |
Rosenfeld PJ, Flynn HW Jr, McDonald HR. Outcomes of vitreoretinal surgery in patients with X-linked retinoschisis. |
||
|
|
|
Ophthalmic Surg Lasers 1998; 29:190-7. |
41. |
Prenner JL, Capone A Jr, Trese MT. Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of |
||
|
|
|
prematurity. Ophthalmology 2004; 111:2271-3. |
42. |
TreseM,ACaponeJr.Chapter24.PadiatricrhegmatogenousretinaldetachmentInHartnettM(Eds).PediatricRetina, |
||
|
|
|
Lippincott A Williams and Wilkins 2005;365-76. |
43. |
Jandeck C, Kellner U, Foerster MH. Late retinal detachment in patients born prematurely—outcome of primary pars |
||
|
|
|
plana vitrectomy. Arch Ophthalmol 2004; 122:61-4. |
44. |
Machemer R. Late tractional retinal detachment in retinopathy of prematurity or ROP like cases. Graefes Arch Clin |
||
|
|
|
Exp Ophthalmol 1993; 231:389-94. |
45. |
Tasman W. Discussion of “Adult retinopathy of prematurity”. Ophthalmology 2001; 108:1653. |
||
46. |
Trese MT, Ferrone PJ. The role of inner wall retinectomy in the management of juvenile retinoschisis. Graefes Arch |
||
|
|
|
Clin Exp Ophthalmol 1995; 233:706-8. |
47. |
Snead MP. Hereditary vitreopathy. Eye 1996; 10:653-63. |
||
48. |
SharmaT,GopalL,ShanmugamMP,etal.RetinaldetachmentinMarfansyndrome:clinicalcharacteristicsandsurgical |
||
|
|
|
outcome. Retina 2002; 22:423-8. |
49. |
GonzalesCR,SinghS,YuF,etal.Pediatricrhegmatogenousretinaldetachment:clinicalfeaturesandsurgicaloutcomes. |
||
|
|
|
Retina 2008;28:847-52. |
|
50. |
Horle S, Schmidt J, Kroll P. Vitreoretinal surgery in complicated retinal detachment in children and adolescents. |
|
|
|||
240 |
|
|
Ophthalmologe 2000; 97:482-6. |
51. |
Moisseiev J, Vidne O, Treister G. Vitrectomy and silicone oil injection in pediatric patients. Retina 1998; 18:221-7. |
||
Textbook of Vitreoretinal Diseases and Surgery
Introduction
Retinoblastoma is the most common intraocular tumor in children. Many tumors possibly arise in infancy or childhood but do not present until later in life like melanocytoma and choroidal osteoma. The other common intraocular tumors in children include juvenile xanthogranuloma, medulloepithelioma, circumscribed choroidal hemangioma, choroidal osteoma, congenital hypertrophy of the retinal pigment epithelium, combined hamartoma of the retina and retinal pigment epithelium and tumors associated with the phacomatoses—von Hippel Lindau syndrome, tuberous sclerosis, neurofibromatosis and Wyburn Mason syndrome.
Epidemiology
Retinoblastoma is the most common intraocular malignant tumor in children with a reported incidence of 1 in 15000 to 1 in 18000 live births.1 The tumor is bilateral in 25% to 35% cases.2 Until recently, enucleation was considered the standard treatment modality for children affected by this tumor. Early diagnosis and recent advances in management like use of chemotherapy and protocol based management strategy have improved the prognosis of this potentially fatal tumor.
Clinical Presentation of Retinoblastoma (Figures 20-1A to G)
Leukocoria is the most common clinical presentation seen in about 56% of patients.3 Other less common presentations include squint, hypopyon, hyphema, vitreous hemorrhage. More advanced cases may present with tumor necrosis and sterile orbital inflammation or with extraocular extension and proptosis.4 Extraocular extension is most likely to occur at the sites of the scleral emissary veins. Atypical clinical manifestations include hypopyon with anterior segment invasion or spontaneous phthisis bulbi.5 Metastasis can occur in long standing and neglected cases and is most commonly seen in brain, skull, distant bones and lymph nodes.
The clinical appearance of the fundus lesion varies with type of tumor growth. Three patterns of tumor growth are usually recognized.4
1.Endophytic tumor: Here the tumor grows as a yellow-white mass lesion from the retinal surface towards the vitreous cavity and can eventually give rise to vitreous seeds. Retinal vessels are not seen on the surface of the tumor and there is no associated retinal detachment.
2.Exophytic tumor grows under the retinal surface giving rise to retinal detachment.
3.Diffuse infiltrating tumor involves the retinal surface as a placoid thickening. This is usually seen in older children and can present with secondary glaucoma.
In a child presenting with leucokoria, other causes like persistent hyperplastic primary vitreous,
Coats’ disease, ocular toxocariasis, endogenous endophthalmitis should be excluded before embarking on the definitive treatment of retinoblastoma.
A dilated fundus evaluation with an indirect ophthalmoscope is useful to diagnose retinoblastoma in 90% cases. An examination under anesthesia is required in every case and should include measurement of corneal dimensions, intraocular pressure, iris and anterior chamber examination for any neovascularization and anterior chamber seeding. Subtle proptosis of the affected eye could be an indicator of extraocular tumor extension and should be looked for.4 It is important to evaluate
242 the fundus thoroughly with indentation of the periphery to detect any peripheral tumor. 3 Ultrasound
Pediatric Intraocular Tumors–I
FIGURE 20-1B:Large exophytic tumor involving more than 75% of the vitreous volume with total retinal detachment
FIGURE 20-1A:Leucokoria is the most common presentation of retinoblastoma, which is seen in the left eye of this 2 year old child. In addition there is esotropia
FIGURE 20-1C:An endophytic tumor is seen |
243 |
with the presence of overlying vitreous seeds |
|
Textbook of Vitreoretinal Diseases and Surgery
FIGURE 20-1E:Rarer presentations include spontaneous phthisis bulbi following tumor necrosis
FIGURE 20-1D:Retinoblastoma may present with involvement of the anterior segment. This 4-year-old child presented with pseudohypopyon in the right eye
FIGURE 20-1F:This 5-year-old child had hyphema following trivial trauma. Hyphema drainage was performed. The child presented after 4 months with extraocular
244 extension of retinoblastoma which manifested as conjunctival masses
Pediatric Intraocular Tumors–I
FIGURE 20-1G:Orbital retinoblastoma may occur following extraocular extension of primary retinoblastoma. This may present as a fungating mass. This 5-year-old child had leucocoria since the age of 2 years
B-scan can be used to measure the tumor dimensions and is especially useful in cases with media opacity like hyphema or vitreous hemorrhage. B scan appearance of intralesional hyper-reflectivity suggesting calcification within the tumor is characteristic of retinoblastoma (Figure 20-2).4 Computed tomography and magnetic resonance imaging is required if any extraocular extension or intracranial tumor spread is suspected (Figure 20-3). Also, in cases with diagnostic dilemma, CT scan can detect the typical intraocular calcification of retinoblastoma. Any associated pinealoblastoma or trilateral retinoblastoma can be detected by CT scan or MRI (Figure 20-4).4
Classification of Retinoblastoma
Reese Ellsworth has been the most widely used system of classification of retinoblastoma for many years.6 This classification was originally devised to predict the prognosis following external beam radiotherapy. In recent years, the appropriateness of this classification has been questioned as it is not useful to prognosticate chemoreduction, the current favored treatment for management of retinoblastoma. The new International Classification of Intraocular Retinoblastoma is a sequential tumor grading which correlates better with the treatment outcome (Table 20-1).7,8
Management
Management of retinoblastoma requires a multimodality approach involving an ocular oncologist, 245 pediatric oncologist, radiation oncologist; geneticist and ocular oncopathologist. The primary goal
Textbook of Vitreoretinal Diseases and Surgery
FIGURE 20-2:Ultrasound B-scan of the left eye of a child with retinoblastoma with the presence of an intraocular mass and high relflective spots within suggestive of intraocular calcification. On the A-scan there is presence of corresponding high spikes
TABLE 20-1: International classification of intraocular retinoblastoma
Group A: Small tumor (< 3 mm) outside macula.
Group B: Tumor > 3 mm or any macular tumor or any tumor with subretinal fluid. Group C: Localised subretinal or vitreous seeds.
Group D: Diffuse subretinal or vitreous seeds
Group E: Tumor touching the lens, neovascular glaucoma, tumor anterior to anterior vitreous face involving ciliary body or anterior segment, diffuse infiltrating retinoblastoma, opaque media from hemorrhage, tumor necrosis with aseptic orbital cellulitis, phthisis bulbi.
of management of retinoblastoma is to safeguard the life of the child. Salvage of the eye and vision are the secondary and tertiary goals respectively. Management is based on the stage of the disease at presentation—intraocular retinoblastoma, retinoblastoma with high-risk factors, orbital
246 retinoblastoma and metastatic retinoblastoma.
Pediatric Intraocular Tumors–I
FIGURE 20-3: Computed tomographic image of a case of orbital retinoblastoma showing tumor extension till orbital apex
FIGURE 20-4: Computed tomographic image of the brain of a child with ocular involvement by retinoblastoma showing the presence of a pinealoblastoma
INTRAOCULAR RETINOBLASTOMA
Management options for intraocular retinoblastoma can be in the form of focal or local therapy and systemic chemotherapy. Focal therapy includes cryotherapy, transpupillary thermotherapy, laser photocoagulation and plaque brachytherapy. Local therapy can be either external beam radiotherapy or enucleation.
Cryotherapy
Cryotherapy is most useful for small peripheral tumors measuring up to 4 mm in diameter and 2 mm in thickness.2,4 Triple freeze thaw cryotherapy is usually applied at 4-6 week intervals until complete tumor regression. Cryotherapy administered before chemotherapy can have a synergistic effect by increasing the delivery of chemotherapeutic agents across the blood retinal barrier.4 Complications of cryotherapy includes serous retinal detachment, retinal tear and rhegmatogenous retinal detachment.
Laser Photocoagulation
The delivery of laser has improved with the use of the indirect ophthalmoscope laser photocoagulation system. The tumor is surrounded by 2 rows of laser burns to cordon off the blood supply to the tumor and never treated directly.2,4 There is a 30% recurrence rate with this modality. Complications include transient serous retinal detachment, retinal vascular occlusion, retinal traction and preretinal fibrosis.
Transpupillary Thermotherapy
The mechanism of thermotherapy is different from classic laser photocoagulation in that the temperature rise is lower than that of photocoagulation.9 The thermal effect of the sub photocoagulation laser leads to the apoptosis of the tumor cells. The tumor is treated directly sparing 247
